Antiplatelet autoantibody-related microparticles in patients with idiopathic (autoimmune) thrombocytopenic purpura
- 33 Downloads
We used flow cytometry to detect antiplatelet antibody-related microparticles (MP) in 56 patients with idiopathic thrombocytopenic purpura (ITP). We measured MP in platelets following various types of stimulation in two experimental systems. In one system washed platelets were incubated with normal serum which included the complement system, and in the other, washed platelets were incubated with Tyrode's buffer. There were no differences between the two measurement systems in the degree of increase in MP using various agonists. An increase in MP using ITP plasma was found in 12 out of 56 patients. In particular, four patients showed a significant increase in MP in washed platelets (WP) plus serum. Furthermore, the increase in platelet-associated IgM (PAIgM) was significant in these patients. There was also a definite positive correlation between PAIgM and the percentage of MP of WP plus serum. On the other hand, no specificity for MP formation with anti-GPIIb/IIIa or anti-GPIb autoantibodies was observed. IgM antibody-related MP appear to exist in some patients with ITP.
Key wordsIdiopathic thrombocytopenic purpura Microparticles Platelet associated IgM Flow cytometry
Unable to display preview. Download preview PDF.
- 16.Nomura S, Kokawa T (1990) Recent advance on analysis of antiplatelet antibody — special reference to application of flow cytometry. In: Okuda K (ed) Automation and new technology in the clinical laboratory. Oxford, Blackwell Scientific Publications, pp. 287–294Google Scholar
- 18.Nomura S, Nagata H, Sone N, Oda K, Kokawa T, Yasunaga K (1988) Analysis of platelet antigen for anti-platelet antibodies in idiopathic thrombocytopenic purpura using flow cytometry. Acta Haematol Jpn 51: 118–129Google Scholar
- 20.Panzer S, Szamait S, Bodeker R-H, Haas OA, Hausenstock A, Mueller-Eckhardt C (1986) Platelet-associated immunoglobulins IgG, IgM, IgA and complement C3 in immune and non-immune thrombocytopenic disorders. Am J Haematol 23: 89–99Google Scholar